Ann: Annual Report to Shareholders, page-37

First 37 Last

Share
Profile

Follow
meghotcop

650 Posts.

207

07/09/21

20:07

Post #: 55902612
Share

Originally posted by Exalted: ↑

Dr Sud has had options he acquired as part of the Cannvalate Agreement in 2019.
Those ranged from 2c-14c sets of options attached with milestones.

He achieved about 3 or 4 sets of options, and exercised up to 6c options. 2,3,4,6 I believe.

That has made him currently the second largest shareholder of the company. So far he has not sold a single share despite being up an absolute truckload. He's our CMO, if he ever buys or sells there's an announcement made to the market.

He is also the medical mind behind the company, now along with Dr Paul. He has stated many times in interviews that he thinks IHL's drugs are able to go global and Joel Latham has stated we are following in GW Pharma's steps.

Sud is also loaded, extremely rich from his business ventures before joining IHL. He doesnt need to sell shares and hes never sold a IHL share.
He is obviously positioning for a buyout in the future, as we continue to walk in GW Pharma's footsteps.

As other posters have said, the Roth Capital Raise is coming after we vote to go on the NASDAQ. Roth's track record shows that after they raise the share price appreciates dramatically, then they do a followup raise.

We will be cashed to the absolute tits soon, I will take that you ask in good faith but a bit of research into Sud and his shareholding would lead you to realize his aims and history real quick.

Expand

Don't get me the wrong way. I haven't got the time to be a troll. ... Just questioning the projections / conjectures of the holders to make up my own mind. BTW, questions that I ask myself.

IHL Price at posting: 40.5¢ Sentiment: None Disclosure: Not Held
8 Upvote

0 Great analysis

Reply

Top Stories

LU7

Lithium Universe 'dream team' ready to step into the demand-supply breach in Canada

MAY

HotCopper users liking Melbana Energy's news it's becoming an oil producer; shares jump +47%

S&P 500 futures dip during non-deciding Trump-Harris Debate; bullish for energy

REA

UK-based Rightmove knocks back REA Group's acquisition proposal

PIQ

Proteomics ends deal with Sonic Healthcare for US commercialisation of kidney disease test

There are more pages in this discussion • 51 more messages in this thread...

First 37 Last

Add IHL (ASX) to my watchlist

Ann: Annual Report to Shareholders, page-37

Top Stories

Lithium Universe 'dream team' ready to step into the demand-supply breach in Canada

HotCopper users liking Melbana Energy's news it's becoming an oil producer; shares jump +47%

S&P 500 futures dip during non-deciding Trump-Harris Debate; bullish for energy

UK-based Rightmove knocks back REA Group's acquisition proposal

Proteomics ends deal with Sonic Healthcare for US commercialisation of kidney disease test

Featured News